Desq Long
Sign in

Company

Immunovant, Inc.

IMVT · CIK 0001764013

SEC FORM 4
$75,099.30

Immunovant, Inc. (IMVT)

Sale of 2,595 shares at $28.94 per share.

Reporting Person Stout Jay S · Officer Title Chief Technology Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001764013-26-000114 · filed 2026-10-23 · View filing →

SEC FORM 4
$70,948.78

Immunovant, Inc. (IMVT)

Sale of 2,213 shares at $32.06 per share.

Reporting Person Stout Jay S · Officer Title Chief Technology Officer · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001702969-26-000012 · filed 2026-10-09 · View filing →

SEC FORM 4
$51,167.76

Immunovant, Inc. (IMVT)

Sale of 1,596 shares at $32.06 per share.

Reporting Person Stout Jay S · Officer Title Chief Technology Officer · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001702969-26-000012 · filed 2026-10-09 · View filing →

SEC FORM 4
$71,846.46

Immunovant, Inc. (IMVT)

Sale of 2,241 shares at $32.06 per share.

Reporting Person Gloria Melanie · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001764013-26-000112 · filed 2026-10-09 · View filing →

SEC FORM 4
$42,543.62

Immunovant, Inc. (IMVT)

Sale of 1,327 shares at $32.06 per share.

Reporting Person Van Tuyl Christopher · Officer Title Chief Legal Officer · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001779707-26-000009 · filed 2026-10-09 · View filing →

SEC FORM 4
$119,589.66

Immunovant, Inc. (IMVT)

Sale of 3,506 shares at $34.11 per share.

Reporting Person Venker Eric · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001764013-26-000110 · filed 2026-10-05 · View filing →

SEC FORM 4
$1,333,024.02

Immunovant, Inc. (IMVT)

Acquisition (code M) of 92,187 shares at $14.46 per share.

Reporting Person Venker Eric · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001764013-26-000110 · filed 2026-10-05 · View filing →

SEC FORM 4
$103,480.56

Immunovant, Inc. (IMVT)

Sale of 2,846 shares at $36.36 per share.

Reporting Person Van Tuyl Christopher · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001764013-26-000108 · filed 2026-09-25 · View filing →

SEC FORM 4
$12,645.00

Immunovant, Inc. (IMVT)

Acquisition (code M) of 1,500 shares at $8.43 per share.

Reporting Person Pande Atul · Transaction Code M

Traded Aug 28, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001764013-26-000103 · filed 2026-08-28 · View filing →

SEC FORM 4
$64,905.00

Immunovant, Inc. (IMVT)

Sale of 1,500 shares at $43.27 per share.

Reporting Person Pande Atul · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001764013-26-000103 · filed 2026-08-28 · View filing →

SEC FORM 4
$134,952.96

Immunovant, Inc. (IMVT)

Sale of 3,056 shares at $44.16 per share.

Reporting Person Gloria Melanie · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001973838-26-000007 · filed 2026-08-21 · View filing →

Immunovant, Inc. (IMVT) · Desq Long